+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Finasteride Market - Global Forecast 2026-2032- Product Image
Finasteride Market - Global Forecast 2026-2032- Product Image
New

Finasteride Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5967736
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The finasteride market is undergoing accelerated transition, with evolving clinical practices, regulatory oversight, and distribution models introducing complexity and opportunity for manufacturers and other stakeholders. As organizations seek to reinforce their competitive position in this sector, the ability to align product strategy with dynamic market requirements grows increasingly important.

Market Snapshot: Growth and Opportunity in the Finasteride Market

The Finasteride Market expanded from USD 126.55 million in 2025 to USD 129.70 million in 2026 and is projected to sustain a compound annual growth rate (CAGR) of 2.91%, reaching USD 154.72 million by 2032. This steady growth underscores the persistent demand for finasteride across a spectrum of therapeutic areas and patient segments.

Scope & Segmentation

  • Route of Administration: Oral (Capsule, Tablet) and Topical (Foam, Solution) approaches provide patients and prescribers with differentiated clinical and adherence profiles.
  • Product Type: Branded (Innovator Brands, Licensed Brands) and Generic (Local Manufacturer, Multinational Manufacturer) products enable varied positioning on evidence, patient support, price, and supply reliability.
  • Strengths: Key dosage forms include 1 mg and 5 mg, targeting different populations and indications.
  • Indications: Androgenic Alopecia (Female Pattern Hair Loss, Male Pattern Baldness) and Benign Prostatic Hyperplasia (Mild, Moderate to Severe cases) address diverse clinical needs.
  • Distribution Channels: Hospital Pharmacy (Private, Public), Online Pharmacy (Manufacturer Website, Third-Party E-Retailer), and Retail Pharmacy (Chain, Independent) expand market penetration and influence access pathways.
  • End Users: Clinics (Dermatology, Urology), Home Care (Self-Medication), and Hospitals (Private, Public) shape intervention and support strategies at multiple care levels.
  • Regional Focus: Americas, Europe, Middle East & Africa, and Asia-Pacific regions—each with distinct regulatory, reimbursement, and commercial frameworks—influence innovation adoption, supply dynamics, and market access strategies.

Therapeutic Positioning and Competitive Landscape

The report provides a comprehensive overview of how finasteride’s established role in androgenic alopecia and benign prostatic hyperplasia intersects with commercial and regulatory imperatives at both local and global levels.

Key Takeaways for Strategic Decision-Makers

  • Market dynamics are increasingly shaped by the demand for differentiated formulations, especially as topical and oral options cater to varied patient needs and regulatory scrutiny intensifies.
  • Manufacturers are investing in pharmacovigilance and real-world evidence programs to support evolving regulatory requirements and reinforce clinical confidence among prescribers and payers.
  • The shift towards digital health and telemedicine is expanding patient access, prompting manufacturers to enhance omnichannel distribution strategies and streamline access through online and retail pharmacy channels.
  • Collaboration through licensing, contract manufacturing, and co-marketing arrangements is facilitating market entry and product rollout while sharing operational and investment risks across partners.
  • Regional manufacturing investments and supplier diversification, accelerated by shifts in global trade policy, are fostering supply chain resilience and enabling adaptation to cost volatility.

Tariff Impact and Supply Chain Realignment

Recent adjustments to United States tariffs on key pharmaceutical components and packaging have resulted in substantial supply chain readjustments among finasteride suppliers. Manufacturers are recalibrating sourcing strategies, regionalizing production processes, and prioritizing strategic partnerships to maintain consistent supply, manage landed costs, and protect margins.

Methodology & Data Sources

This analysis leverages primary interviews with clinicians, commercial leaders, and distribution specialists, along with a rigorous review of regulatory documents, product labeling, and public safety data. Findings are grounded in expert perspectives and validated through secondary sources, scenario modelling, and case study review to ensure robust, actionable conclusions.

Why This Report Matters

  • Supports strategic decision-making with actionable insights into evolving clinical, regulatory, and competitive trends in the finasteride market.
  • Enables manufacturers, distributors, and investors to align commercialization, supply chain, and access strategies with emerging market requirements and policy changes.
  • Helps industry leaders future-proof their portfolios by highlighting areas for product differentiation, partnership, and supply resilience.

Conclusion

Adapting to clinical expectations, regulatory developments, and distribution innovations is essential for sustained success in the finasteride market. Stakeholders that prioritize evidence, differentiated formulations, robust supply chains, and agile commercialization will be best placed to capture future opportunity.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Finasteride Market, by Route Of Administration
8.1. Oral
8.1.1. Capsule
8.1.2. Tablet
8.2. Topical
8.2.1. Foam
8.2.2. Solution
9. Finasteride Market, by Product Type
9.1. Branded
9.1.1. Innovator Brands
9.1.2. Licensed Brands
9.2. Generic
9.2.1. Local Manufacturer
9.2.2. Multinational Manufacturer
10. Finasteride Market, by Strength
10.1. 1 Mg
10.2. 5 Mg
11. Finasteride Market, by Indication
11.1. Androgenic Alopecia
11.1.1. Female Pattern Hair Loss
11.1.2. Male Pattern Baldness
11.2. Benign Prostatic Hyperplasia
11.2.1. Mild BPH
11.2.2. Moderate To Severe BPH
12. Finasteride Market, by Distribution Channel
12.1. Online Pharmacy
12.1.1. Manufacturer Website
12.1.2. Third Party E-Retailer
12.2. Offline
13. Finasteride Market, by End User
13.1. Clinics
13.1.1. Dermatology Clinics
13.1.2. Urology Clinics
13.2. Home Care
13.3. Hospitals
13.3.1. Private Hospitals
13.3.2. Public Hospitals
14. Finasteride Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Finasteride Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Finasteride Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Finasteride Market
18. China Finasteride Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Accord Pharmaceuticals
19.6. Alkem Labs Ltd
19.7. Amgen
19.8. AstraZeneca
19.9. Aurobindo Pharma
19.10. Canixa Life Sciences Pvt Ltd
19.11. Cipla
19.12. Dr. Reddy's Laboratories Ltd.
19.13. Eli Lilly
19.14. Gedeon Richter
19.15. GSK
19.16. Hetero Labs
19.17. Intas Pharmaceuticals Ltd.
19.18. Johnson & Johnson
19.19. Lupin Ltd.
19.20. MSN Labs
19.21. Mylan N.V.
19.22. Novartis AG
19.23. Sanofi
19.24. Sun Pharma
19.25. Teva Pharmaceutical Industries Ltd.
List of Figures
FIGURE 1. GLOBAL FINASTERIDE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL FINASTERIDE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL FINASTERIDE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL FINASTERIDE MARKET SIZE, BY STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL FINASTERIDE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL FINASTERIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES FINASTERIDE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA FINASTERIDE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL FINASTERIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL FINASTERIDE MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL FINASTERIDE MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL FINASTERIDE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL FINASTERIDE MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL FINASTERIDE MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL FINASTERIDE MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL FINASTERIDE MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL FINASTERIDE MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL FINASTERIDE MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL FINASTERIDE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL FINASTERIDE MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL FINASTERIDE MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL FINASTERIDE MARKET SIZE, BY FOAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL FINASTERIDE MARKET SIZE, BY FOAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL FINASTERIDE MARKET SIZE, BY FOAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL FINASTERIDE MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL FINASTERIDE MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL FINASTERIDE MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FINASTERIDE MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FINASTERIDE MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FINASTERIDE MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL FINASTERIDE MARKET SIZE, BY INNOVATOR BRANDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL FINASTERIDE MARKET SIZE, BY INNOVATOR BRANDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL FINASTERIDE MARKET SIZE, BY INNOVATOR BRANDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FINASTERIDE MARKET SIZE, BY LICENSED BRANDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FINASTERIDE MARKET SIZE, BY LICENSED BRANDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FINASTERIDE MARKET SIZE, BY LICENSED BRANDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL FINASTERIDE MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL FINASTERIDE MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL FINASTERIDE MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL FINASTERIDE MARKET SIZE, BY LOCAL MANUFACTURER, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL FINASTERIDE MARKET SIZE, BY LOCAL MANUFACTURER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL FINASTERIDE MARKET SIZE, BY LOCAL MANUFACTURER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL FINASTERIDE MARKET SIZE, BY MULTINATIONAL MANUFACTURER, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL FINASTERIDE MARKET SIZE, BY MULTINATIONAL MANUFACTURER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL FINASTERIDE MARKET SIZE, BY MULTINATIONAL MANUFACTURER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL FINASTERIDE MARKET SIZE, BY 1 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL FINASTERIDE MARKET SIZE, BY 1 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL FINASTERIDE MARKET SIZE, BY 1 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL FINASTERIDE MARKET SIZE, BY 5 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL FINASTERIDE MARKET SIZE, BY 5 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL FINASTERIDE MARKET SIZE, BY 5 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL FINASTERIDE MARKET SIZE, BY FEMALE PATTERN HAIR LOSS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL FINASTERIDE MARKET SIZE, BY FEMALE PATTERN HAIR LOSS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FINASTERIDE MARKET SIZE, BY FEMALE PATTERN HAIR LOSS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL FINASTERIDE MARKET SIZE, BY MALE PATTERN BALDNESS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL FINASTERIDE MARKET SIZE, BY MALE PATTERN BALDNESS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL FINASTERIDE MARKET SIZE, BY MALE PATTERN BALDNESS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL FINASTERIDE MARKET SIZE, BY MILD BPH, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FINASTERIDE MARKET SIZE, BY MILD BPH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FINASTERIDE MARKET SIZE, BY MILD BPH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL FINASTERIDE MARKET SIZE, BY MODERATE TO SEVERE BPH, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL FINASTERIDE MARKET SIZE, BY MODERATE TO SEVERE BPH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL FINASTERIDE MARKET SIZE, BY MODERATE TO SEVERE BPH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL FINASTERIDE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL FINASTERIDE MARKET SIZE, BY MANUFACTURER WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL FINASTERIDE MARKET SIZE, BY MANUFACTURER WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL FINASTERIDE MARKET SIZE, BY THIRD PARTY E-RETAILER, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL FINASTERIDE MARKET SIZE, BY THIRD PARTY E-RETAILER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL FINASTERIDE MARKET SIZE, BY THIRD PARTY E-RETAILER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL FINASTERIDE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL FINASTERIDE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL FINASTERIDE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL FINASTERIDE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL FINASTERIDE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL FINASTERIDE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL FINASTERIDE MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL FINASTERIDE MARKET SIZE, BY DERMATOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL FINASTERIDE MARKET SIZE, BY DERMATOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL FINASTERIDE MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL FINASTERIDE MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL FINASTERIDE MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL FINASTERIDE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL FINASTERIDE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL FINASTERIDE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL FINASTERIDE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL FINASTERIDE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL FINASTERIDE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL FINASTERIDE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL FINASTERIDE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL FINASTERIDE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL FINASTERIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS FINASTERIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 145. LATIN AMERICA FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 175. EUROPE FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. EUROPE FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 177. EUROPE FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 178. EUROPE FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 179. EUROPE FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. EUROPE FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 181. EUROPE FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 182. EUROPE FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 183. EUROPE FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 184. EUROPE FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 185. EUROPE FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 186. EUROPE FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 187. EUROPE FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 188. EUROPE FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. EUROPE FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 190. EUROPE FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 198. MIDDLE EAST FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 199. MIDDLE EAST FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 200. MIDDLE EAST FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 201. MIDDLE EAST FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 202. MIDDLE EAST FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 207. AFRICA FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. AFRICA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 209. AFRICA FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 210. AFRICA FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 211. AFRICA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. AFRICA FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 213. AFRICA FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 214. AFRICA FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 215. AFRICA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 216. AFRICA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 217. AFRICA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 218. AFRICA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 219. AFRICA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 220. AFRICA FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. AFRICA FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 222. AFRICA FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 226. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 227. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 228. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 229. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 230. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 231. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 232. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL FINASTERIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 240. ASEAN FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 241. ASEAN FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 242. ASEAN FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 243. ASEAN FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 244. ASEAN FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 245. ASEAN FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 246. ASEAN FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 247. ASEAN FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 248. ASEAN FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 249. ASEAN FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 250. ASEAN FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 251. ASEAN FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. ASEAN FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 253. ASEAN FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 254. ASEAN FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 255. ASEAN FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 256. GCC FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 257. GCC FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 258. GCC FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 259. GCC FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 260. GCC FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 261. GCC FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 262. GCC FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 263. GCC FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 264. GCC FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 265. GCC FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 266. GCC FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 267. GCC FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 268. GCC FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 269. GCC FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. GCC FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 271. GCC FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 272. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 273. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 274. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 275. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 276. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 277. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 288. BRICS FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 289. BRICS FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 290. BRICS FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 291. BRICS FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 292. BRICS FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 293. BRICS FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 294. BRICS FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 295. BRICS FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 296. BRICS FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 297. BRICS FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 298. BRICS FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 299. BRICS FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 300. BRICS FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 301. BRICS FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 302. BRICS FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 303. BRICS FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 304. G7 FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 305. G7 FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 306. G7 FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 307. G7 FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 308. G7 FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 309. G7 FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 310. G7 FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 311. G7 FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 312. G7 FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 313. G7 FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 314. G7 FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 315. G7 FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 316. G7 FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 317. G7 FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 318. G7 FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 319. G7 FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 320. NATO FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 321. NATO FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 322. NATO FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 323. NATO FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 324. NATO FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 325. NATO FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 326. NATO FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 327. NATO FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 328. NATO FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 329. NATO FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 330. NATO FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 331. NATO FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 332. NATO FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 333. NATO FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 334. NATO FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 335. NATO FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 336. GLOBAL FINASTERIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 337. UNITED STATES FINASTERIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 338. UNITED STATES FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 339. UNITED STATES FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 340. UNITED STATES FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 341. UNITED STATES FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 342. UNITED STATES FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 343. UNITED STATES FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 344. UNITED STATES FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 345. UNITED STATES FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 346. UNITED STATES FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 347. UNITED STATES FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 348. UNITED STATES FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 349. UNITED STATES FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 350. UNITED STATES FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 351. UNITED STATES FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 352. UNITED STATES FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 353. CHINA FINASTERIDE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 354. CHINA FINASTERIDE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 355. CHINA FINASTERIDE MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 356. CHINA FINASTERIDE MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 357. CHINA FINASTERIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 358. CHINA FINASTERIDE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 359. CHINA FINASTERIDE MARKET SIZE, BY GENERIC, 2018-2032 (USD MILLION)
TABLE 360. CHINA FINASTERIDE MARKET SIZE, BY STRENGTH, 2018-2032 (USD MILLION)
TABLE 361. CHINA FINASTERIDE MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 362. CHINA FINASTERIDE MARKET SIZE, BY ANDROGENIC ALOPECIA, 2018-2032 (USD MILLION)
TABLE 363. CHINA FINASTERIDE MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, 2018-2032 (USD MILLION)
TABLE 364. CHINA FINASTERIDE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 365. CHINA FINASTERIDE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 366. CHINA FINASTERIDE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 367. CHINA FINASTERIDE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
TABLE 368. CHINA FINASTERIDE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Finasteride market report include:
  • Accord Pharmaceuticals
  • Alkem Labs Ltd
  • Amgen
  • AstraZeneca
  • Aurobindo Pharma
  • Canixa Life Sciences Pvt Ltd
  • Cipla
  • Dr. Reddy's Laboratories Ltd.
  • Eli Lilly
  • Gedeon Richter
  • GSK
  • Hetero Labs
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson
  • Lupin Ltd.
  • MSN Labs
  • Mylan N.V.
  • Novartis AG
  • Sanofi
  • Sun Pharma
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 129.7 Million
Forecasted Market Value ( USD ) by 2032 $ 154.72 Million
Compound Annual Growth Rate2.9%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

Finasteride Preparations Market - Global Forecast 2025-2030 - Product Image

Finasteride Preparations Market - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Finasteride Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Finasteride Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 190 Pages
  • Global
From
Cyproterone Acetate Market - Global Strategic Business Report - Product Image

Cyproterone Acetate Market - Global Strategic Business Report

  • Report
  • 287 Pages
  • Global
From
Miglitol Tablets Market - Global Forecast 2026-2032 - Product Image

Miglitol Tablets Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Adenosine Market Report 2025 - Product Image

Adenosine Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the Finasteride Market

Finasteride is a drug used to treat endocrine and metabolic disorders. It is a type II 5-alpha reductase inhibitor, which works by blocking the enzyme responsible for converting testosterone to dihydrotestosterone (DHT). This helps to reduce the symptoms of conditions such as benign prostatic hyperplasia (BPH) and male pattern baldness. Finasteride is also used to treat hirsutism, a condition characterized by excessive hair growth in women. Finasteride is available in both oral and topical formulations. Oral finasteride is typically prescribed for BPH and male pattern baldness, while topical finasteride is used to treat hirsutism. Finasteride is generally well-tolerated, with few side effects. The Finasteride market is a growing one, with many companies offering products for the treatment of endocrine and metabolic disorders. Some of the major players in the market include Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, and Mylan N.V. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.